Bioceres Crop Solutions Corp. BIOX
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.39% | -55.60% | -29.09% | -23.90% | -20.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.39% | -55.60% | -29.09% | -23.90% | -20.28% |
| Cost of Revenue | -23.93% | -45.42% | -11.64% | -30.01% | -24.45% |
| Gross Profit | -5.17% | -72.87% | -46.27% | -13.00% | -13.13% |
| SG&A Expenses | -19.33% | 9.36% | -1.51% | 4.50% | -15.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -48.35% | -71.20% | -342.50% | -20.98% | -0.38% |
| Total Operating Expenses | -21.35% | -36.55% | -19.55% | -20.96% | -20.22% |
| Operating Income | 133.88% | -275.74% | -84.73% | -48.89% | -21.95% |
| Income Before Tax | 28.12% | -843.60% | -163.45% | -95.76% | -231.84% |
| Income Tax Expenses | 264.48% | 261.37% | -319.14% | -102.39% | -395.20% |
| Earnings from Continuing Operations | -20.17% | -5,088.86% | -116.27% | -51.13% | -131.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 170.27% | 609.09% | 155.20% | 59.15% | 91.05% |
| Net Income | -15.05% | -9,490.69% | -114.09% | 32.38% | -38.72% |
| EBIT | 133.88% | -275.74% | -84.73% | -48.89% | -21.95% |
| EBITDA | 57.26% | -215.48% | -61.78% | -37.12% | -0.83% |
| EPS Basic | -14.02% | -9,473.42% | -114.12% | 35.29% | -38.58% |
| Normalized Basic EPS | 33.77% | -- | -164.28% | -104.27% | -45.83% |
| EPS Diluted | -14.02% | -9,473.42% | -115.00% | 35.29% | -38.58% |
| Normalized Diluted EPS | 33.77% | -- | -168.32% | -104.34% | -45.83% |
| Average Basic Shares Outstanding | 0.92% | 0.64% | -0.08% | -0.03% | 0.01% |
| Average Diluted Shares Outstanding | 0.92% | -0.94% | -5.95% | -1.11% | 0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |